Calculating the Future of CMS Payments

Article Type
Changed
Fri, 09/14/2018 - 12:39
Display Headline
Calculating the Future of CMS Payments

Hospitalists and other physicians with Medicare patients are awaiting final word on proposed changes to the Medicare Physician Fee Schedule, due to take effect next year.

How, exactly, will the fee changes affect you? What will your revenue look like in 2007? You can find answers to these questions by understanding what the changes will be and by using a new online tool developed by the American College of Physicians (ACP).

A Look at the Proposed Payment Changes

The Centers for Medicare and Medicaid Services (CMS) has proposed specific changes to the Medicare Physician Fee Schedule that would significantly increase payments for Medicare beneficiaries’ hospital visits, office visits, consultations, and other evaluation and management (E/M) services. If the proposed changes are enacted, Medicare payments would substantially increase for these services. How substantial are the increases? The work relative value unit (RVU) for initial hospital care (CPT code 99221) would increase by 47%, and the work RVU for subsequent hospital care (CPT code 99232) would increase by 31%. (For a detailed breakdown of the “Impact of the Proposed Rule on E/M Codes Billed by Hospitalists,” see p. 38.)

How will these proposed increases affect your income? The dollar amount is difficult to calculate, partly because, due to legislative restrictions, Medicare payments won’t increase by the same percentage as the E/M relative values. CMS can make only budget-neutral changes. This means it can’t increase payments by more than $20 million per year. Because the proposed 2007 changes exceed this amount—they come close to $4 billion—CMS has proposed an additional adjustment that reduces payment equally for all physician services in order to maintain 2007 expenditures at roughly their 2006 level. This adjustment means that payment for some low-level E/M services will decrease.

IMPACT OF PROPOSED RULE ON E/M CODES BILLED BY HOSPITALISTS
click for large version
click for large version

An Online Calculator Can Help

The ACP has developed an interactive revenue calculator to enable its members to estimate their reimbursements under the proposed changes. Available for members only on the ACP Web site (www.acponline.org/private/pmc/emimpact.html), the calculator estimates the potential revenue change for E/M services only.

“We thought [the calculator] would be helpful to our members,” explains Brian Whitman, senior analyst for Regulatory and Insurer Affairs, ACP. “The RVU changes are technical and complex, and it’s hard for a practicing physician to translate the changes. Doctors see dollars, not RVUs. Also, the changes all depend on the volume of Medicare patients they have and how they code.”

Physicians who use the ACP reimbursement calculator enter the number of visits they provide to Medicare beneficiaries in a typical week, categorized under individual CPT codes. The calculator then determines their Medicare revenue for 2006 and their projected Medicare revenue for 2007. Finally, it estimates how much their 2007 revenue will change in a typical week and in the upcoming year.

Of course, the Medicare payment received for many non-E/M services will decrease because, as stated earlier, the Medicare statute requires CMS to keep 2007 expenditures at roughly the same level as those generated in 2006.

After using the online calculator to determine their payments from the affected E/M codes, ACP members can then estimate their projected net revenue change. The ACP recommends that physicians estimate their 2006 Medicare revenue for all services not specifically listed in the calculator and then multiply that figure by 0.95 to account for the budget neutrality adjustment. They can then subtract that number from the total payment found in the online calculator to get an estimate of their net Medicare payment change in 2007.

The ACP’s reimbursement calculator is not designed to be precise; that would be impossible. “The calculator itself is an estimate,” warns Whitman. For one thing, the payments per RVU will not be certain until CMS publishes its final 2007 relative values. In addition, E/M service payments by private health plans that use the Medicare-approved RVUs for determining their own fee schedules are likely to increase.

 

 

What Happens Next?

CMS proposed the changes in June. According to the law, CMS must solicit comments from the public for 60 days. Some time after considering these comments, CMS will announce its final decision on the payment changes for E/M and other services. “They usually release their final rule in October or November,” says Whitman. CMS has proposed using the revised RVUs beginning January 1, 2007.

For the latest news on the proposed payment changes, check the SHM Web site at www.hospitalmedicine.org. If you’re a member of the ACP, check out the online reimbursement calculator at www.acponline.org/private/pmc/emimpact.html. TH

Issue
The Hospitalist - 2006(10)
Publications
Sections

Hospitalists and other physicians with Medicare patients are awaiting final word on proposed changes to the Medicare Physician Fee Schedule, due to take effect next year.

How, exactly, will the fee changes affect you? What will your revenue look like in 2007? You can find answers to these questions by understanding what the changes will be and by using a new online tool developed by the American College of Physicians (ACP).

A Look at the Proposed Payment Changes

The Centers for Medicare and Medicaid Services (CMS) has proposed specific changes to the Medicare Physician Fee Schedule that would significantly increase payments for Medicare beneficiaries’ hospital visits, office visits, consultations, and other evaluation and management (E/M) services. If the proposed changes are enacted, Medicare payments would substantially increase for these services. How substantial are the increases? The work relative value unit (RVU) for initial hospital care (CPT code 99221) would increase by 47%, and the work RVU for subsequent hospital care (CPT code 99232) would increase by 31%. (For a detailed breakdown of the “Impact of the Proposed Rule on E/M Codes Billed by Hospitalists,” see p. 38.)

How will these proposed increases affect your income? The dollar amount is difficult to calculate, partly because, due to legislative restrictions, Medicare payments won’t increase by the same percentage as the E/M relative values. CMS can make only budget-neutral changes. This means it can’t increase payments by more than $20 million per year. Because the proposed 2007 changes exceed this amount—they come close to $4 billion—CMS has proposed an additional adjustment that reduces payment equally for all physician services in order to maintain 2007 expenditures at roughly their 2006 level. This adjustment means that payment for some low-level E/M services will decrease.

IMPACT OF PROPOSED RULE ON E/M CODES BILLED BY HOSPITALISTS
click for large version
click for large version

An Online Calculator Can Help

The ACP has developed an interactive revenue calculator to enable its members to estimate their reimbursements under the proposed changes. Available for members only on the ACP Web site (www.acponline.org/private/pmc/emimpact.html), the calculator estimates the potential revenue change for E/M services only.

“We thought [the calculator] would be helpful to our members,” explains Brian Whitman, senior analyst for Regulatory and Insurer Affairs, ACP. “The RVU changes are technical and complex, and it’s hard for a practicing physician to translate the changes. Doctors see dollars, not RVUs. Also, the changes all depend on the volume of Medicare patients they have and how they code.”

Physicians who use the ACP reimbursement calculator enter the number of visits they provide to Medicare beneficiaries in a typical week, categorized under individual CPT codes. The calculator then determines their Medicare revenue for 2006 and their projected Medicare revenue for 2007. Finally, it estimates how much their 2007 revenue will change in a typical week and in the upcoming year.

Of course, the Medicare payment received for many non-E/M services will decrease because, as stated earlier, the Medicare statute requires CMS to keep 2007 expenditures at roughly the same level as those generated in 2006.

After using the online calculator to determine their payments from the affected E/M codes, ACP members can then estimate their projected net revenue change. The ACP recommends that physicians estimate their 2006 Medicare revenue for all services not specifically listed in the calculator and then multiply that figure by 0.95 to account for the budget neutrality adjustment. They can then subtract that number from the total payment found in the online calculator to get an estimate of their net Medicare payment change in 2007.

The ACP’s reimbursement calculator is not designed to be precise; that would be impossible. “The calculator itself is an estimate,” warns Whitman. For one thing, the payments per RVU will not be certain until CMS publishes its final 2007 relative values. In addition, E/M service payments by private health plans that use the Medicare-approved RVUs for determining their own fee schedules are likely to increase.

 

 

What Happens Next?

CMS proposed the changes in June. According to the law, CMS must solicit comments from the public for 60 days. Some time after considering these comments, CMS will announce its final decision on the payment changes for E/M and other services. “They usually release their final rule in October or November,” says Whitman. CMS has proposed using the revised RVUs beginning January 1, 2007.

For the latest news on the proposed payment changes, check the SHM Web site at www.hospitalmedicine.org. If you’re a member of the ACP, check out the online reimbursement calculator at www.acponline.org/private/pmc/emimpact.html. TH

Hospitalists and other physicians with Medicare patients are awaiting final word on proposed changes to the Medicare Physician Fee Schedule, due to take effect next year.

How, exactly, will the fee changes affect you? What will your revenue look like in 2007? You can find answers to these questions by understanding what the changes will be and by using a new online tool developed by the American College of Physicians (ACP).

A Look at the Proposed Payment Changes

The Centers for Medicare and Medicaid Services (CMS) has proposed specific changes to the Medicare Physician Fee Schedule that would significantly increase payments for Medicare beneficiaries’ hospital visits, office visits, consultations, and other evaluation and management (E/M) services. If the proposed changes are enacted, Medicare payments would substantially increase for these services. How substantial are the increases? The work relative value unit (RVU) for initial hospital care (CPT code 99221) would increase by 47%, and the work RVU for subsequent hospital care (CPT code 99232) would increase by 31%. (For a detailed breakdown of the “Impact of the Proposed Rule on E/M Codes Billed by Hospitalists,” see p. 38.)

How will these proposed increases affect your income? The dollar amount is difficult to calculate, partly because, due to legislative restrictions, Medicare payments won’t increase by the same percentage as the E/M relative values. CMS can make only budget-neutral changes. This means it can’t increase payments by more than $20 million per year. Because the proposed 2007 changes exceed this amount—they come close to $4 billion—CMS has proposed an additional adjustment that reduces payment equally for all physician services in order to maintain 2007 expenditures at roughly their 2006 level. This adjustment means that payment for some low-level E/M services will decrease.

IMPACT OF PROPOSED RULE ON E/M CODES BILLED BY HOSPITALISTS
click for large version
click for large version

An Online Calculator Can Help

The ACP has developed an interactive revenue calculator to enable its members to estimate their reimbursements under the proposed changes. Available for members only on the ACP Web site (www.acponline.org/private/pmc/emimpact.html), the calculator estimates the potential revenue change for E/M services only.

“We thought [the calculator] would be helpful to our members,” explains Brian Whitman, senior analyst for Regulatory and Insurer Affairs, ACP. “The RVU changes are technical and complex, and it’s hard for a practicing physician to translate the changes. Doctors see dollars, not RVUs. Also, the changes all depend on the volume of Medicare patients they have and how they code.”

Physicians who use the ACP reimbursement calculator enter the number of visits they provide to Medicare beneficiaries in a typical week, categorized under individual CPT codes. The calculator then determines their Medicare revenue for 2006 and their projected Medicare revenue for 2007. Finally, it estimates how much their 2007 revenue will change in a typical week and in the upcoming year.

Of course, the Medicare payment received for many non-E/M services will decrease because, as stated earlier, the Medicare statute requires CMS to keep 2007 expenditures at roughly the same level as those generated in 2006.

After using the online calculator to determine their payments from the affected E/M codes, ACP members can then estimate their projected net revenue change. The ACP recommends that physicians estimate their 2006 Medicare revenue for all services not specifically listed in the calculator and then multiply that figure by 0.95 to account for the budget neutrality adjustment. They can then subtract that number from the total payment found in the online calculator to get an estimate of their net Medicare payment change in 2007.

The ACP’s reimbursement calculator is not designed to be precise; that would be impossible. “The calculator itself is an estimate,” warns Whitman. For one thing, the payments per RVU will not be certain until CMS publishes its final 2007 relative values. In addition, E/M service payments by private health plans that use the Medicare-approved RVUs for determining their own fee schedules are likely to increase.

 

 

What Happens Next?

CMS proposed the changes in June. According to the law, CMS must solicit comments from the public for 60 days. Some time after considering these comments, CMS will announce its final decision on the payment changes for E/M and other services. “They usually release their final rule in October or November,” says Whitman. CMS has proposed using the revised RVUs beginning January 1, 2007.

For the latest news on the proposed payment changes, check the SHM Web site at www.hospitalmedicine.org. If you’re a member of the ACP, check out the online reimbursement calculator at www.acponline.org/private/pmc/emimpact.html. TH

Issue
The Hospitalist - 2006(10)
Issue
The Hospitalist - 2006(10)
Publications
Publications
Article Type
Display Headline
Calculating the Future of CMS Payments
Display Headline
Calculating the Future of CMS Payments
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)

Peripheral Arterial Disease

Article Type
Changed
Wed, 04/10/2019 - 11:49
Display Headline
Peripheral Arterial Disease
Recognition and contemporary management
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 73(10)
Publications
Topics
Page Number
S1-S51
Sections
Article PDF
Article PDF
Recognition and contemporary management
Recognition and contemporary management
Issue
Cleveland Clinic Journal of Medicine - 73(10)
Issue
Cleveland Clinic Journal of Medicine - 73(10)
Page Number
S1-S51
Page Number
S1-S51
Publications
Publications
Topics
Article Type
Display Headline
Peripheral Arterial Disease
Display Headline
Peripheral Arterial Disease
Sections
Citation Override
Cleveland Clinic Journal of Medicine 2006 October;73(10 suppl 4):S1-S51
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Thu, 09/06/2018 - 07:45
Un-Gate On Date
Thu, 09/06/2018 - 07:45
Use ProPublica
CFC Schedule Remove Status
Thu, 09/06/2018 - 07:45
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Beyond cardiovascular risk: The impact of obesity on cancer death

Article Type
Changed
Wed, 08/22/2018 - 11:18
Display Headline
Beyond cardiovascular risk: The impact of obesity on cancer death
Article PDF
Author and Disclosure Information

Bryan C. Bordeaux, DO, MPH
Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD

Shari Bolen, MD, MPH
Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD

Daniel J. Brotman, MD
Division of General Internal Medicine, Johns Hopkins CREDIT University School of Medicine, Baltimore, MD

Address: Bryan C. Bordeaux, DO, 1830 Building, Room 8011, 600 North Wolfe Street, Baltimore, MD 21287; e-mail bbordea1@jhmi.edu

Issue
Cleveland Clinic Journal of Medicine - 73(10)
Publications
Topics
Page Number
945-950
Sections
Author and Disclosure Information

Bryan C. Bordeaux, DO, MPH
Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD

Shari Bolen, MD, MPH
Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD

Daniel J. Brotman, MD
Division of General Internal Medicine, Johns Hopkins CREDIT University School of Medicine, Baltimore, MD

Address: Bryan C. Bordeaux, DO, 1830 Building, Room 8011, 600 North Wolfe Street, Baltimore, MD 21287; e-mail bbordea1@jhmi.edu

Author and Disclosure Information

Bryan C. Bordeaux, DO, MPH
Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD

Shari Bolen, MD, MPH
Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD

Daniel J. Brotman, MD
Division of General Internal Medicine, Johns Hopkins CREDIT University School of Medicine, Baltimore, MD

Address: Bryan C. Bordeaux, DO, 1830 Building, Room 8011, 600 North Wolfe Street, Baltimore, MD 21287; e-mail bbordea1@jhmi.edu

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 73(10)
Issue
Cleveland Clinic Journal of Medicine - 73(10)
Page Number
945-950
Page Number
945-950
Publications
Publications
Topics
Article Type
Display Headline
Beyond cardiovascular risk: The impact of obesity on cancer death
Display Headline
Beyond cardiovascular risk: The impact of obesity on cancer death
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Coronary atherosclerosis can regress with very intensive statin therapy

Article Type
Changed
Wed, 08/22/2018 - 11:14
Display Headline
Coronary atherosclerosis can regress with very intensive statin therapy
Interpreting the ASTEROID trial
Article PDF
Author and Disclosure Information

Ilke Sipahi, MD
Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

Stephen J. Nicholls, MBBS, PhD
Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

E. Murat Tuzcu, MD
Vice Chairman, Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

Steven E. Nissen, MD
Chairman, Department of Cardiovascular Medicine, Cleveland Clinic; president, American College of Cardiology; principal investigator, ASTEROID trial

Address: Ilke Sipahi, MD, Department of Cardiovascular Medicine, JJ65, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail sipahii@ccf.org

Dr. Sipahi has received an educational grant from Pfizer.

Dr. Nicholls has received lecture honoraria from AstraZeneca and Pfizer.

Dr. Tuzcu received grant support from Pfizer and Takeda and lecture honoraria from Pfizer.

Dr. Nissen has received research support from AstraZeneca, Eli Lilly, Pfizer, Takeda, Sankyo, and Sanofi-Aventis. He has also consulted for a number of pharmaceutical companies without financial compensation. All his honoraria, consulting fees, or other payments from any for-profit entity are paid directly to charity, so that neither income nor tax deduction is received.

Issue
Cleveland Clinic Journal of Medicine - 73(10)
Publications
Topics
Page Number
937-944
Sections
Author and Disclosure Information

Ilke Sipahi, MD
Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

Stephen J. Nicholls, MBBS, PhD
Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

E. Murat Tuzcu, MD
Vice Chairman, Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

Steven E. Nissen, MD
Chairman, Department of Cardiovascular Medicine, Cleveland Clinic; president, American College of Cardiology; principal investigator, ASTEROID trial

Address: Ilke Sipahi, MD, Department of Cardiovascular Medicine, JJ65, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail sipahii@ccf.org

Dr. Sipahi has received an educational grant from Pfizer.

Dr. Nicholls has received lecture honoraria from AstraZeneca and Pfizer.

Dr. Tuzcu received grant support from Pfizer and Takeda and lecture honoraria from Pfizer.

Dr. Nissen has received research support from AstraZeneca, Eli Lilly, Pfizer, Takeda, Sankyo, and Sanofi-Aventis. He has also consulted for a number of pharmaceutical companies without financial compensation. All his honoraria, consulting fees, or other payments from any for-profit entity are paid directly to charity, so that neither income nor tax deduction is received.

Author and Disclosure Information

Ilke Sipahi, MD
Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

Stephen J. Nicholls, MBBS, PhD
Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

E. Murat Tuzcu, MD
Vice Chairman, Department of Cardiovascular Medicine, Cleveland Clinic; investigator, ASTEROID trial

Steven E. Nissen, MD
Chairman, Department of Cardiovascular Medicine, Cleveland Clinic; president, American College of Cardiology; principal investigator, ASTEROID trial

Address: Ilke Sipahi, MD, Department of Cardiovascular Medicine, JJ65, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail sipahii@ccf.org

Dr. Sipahi has received an educational grant from Pfizer.

Dr. Nicholls has received lecture honoraria from AstraZeneca and Pfizer.

Dr. Tuzcu received grant support from Pfizer and Takeda and lecture honoraria from Pfizer.

Dr. Nissen has received research support from AstraZeneca, Eli Lilly, Pfizer, Takeda, Sankyo, and Sanofi-Aventis. He has also consulted for a number of pharmaceutical companies without financial compensation. All his honoraria, consulting fees, or other payments from any for-profit entity are paid directly to charity, so that neither income nor tax deduction is received.

Article PDF
Article PDF
Interpreting the ASTEROID trial
Interpreting the ASTEROID trial
Issue
Cleveland Clinic Journal of Medicine - 73(10)
Issue
Cleveland Clinic Journal of Medicine - 73(10)
Page Number
937-944
Page Number
937-944
Publications
Publications
Topics
Article Type
Display Headline
Coronary atherosclerosis can regress with very intensive statin therapy
Display Headline
Coronary atherosclerosis can regress with very intensive statin therapy
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Using the new HPV vaccines in clinical practice

Article Type
Changed
Wed, 08/22/2018 - 11:05
Display Headline
Using the new HPV vaccines in clinical practice
Article PDF
Author and Disclosure Information

Lea E. Widdice, MD
Assistant Professor of Pediatrics, Division of Adolescent Medicine, Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH

Jessica A. Kahn, MD, MPH
Associate Professor of Pediatrics, Director, Research Training, Division of Adolescent Medicine, Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH; Steering Committee, National Network for Immunization Information; HPV Expert Advisory Group,World Health Organization

Address: Lea E. Widdice, MD, Division of Adolescent Medicine, MLC 4000, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229; e-mail lea.widdice@cchmc.org

Dr. Kahn has disclosed that she has received a consulting fee from the SciMed and Merck corporations for editing a journal supplement on HPV vaccines.

Issue
Cleveland Clinic Journal of Medicine - 73(10)
Publications
Topics
Page Number
929-935
Sections
Author and Disclosure Information

Lea E. Widdice, MD
Assistant Professor of Pediatrics, Division of Adolescent Medicine, Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH

Jessica A. Kahn, MD, MPH
Associate Professor of Pediatrics, Director, Research Training, Division of Adolescent Medicine, Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH; Steering Committee, National Network for Immunization Information; HPV Expert Advisory Group,World Health Organization

Address: Lea E. Widdice, MD, Division of Adolescent Medicine, MLC 4000, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229; e-mail lea.widdice@cchmc.org

Dr. Kahn has disclosed that she has received a consulting fee from the SciMed and Merck corporations for editing a journal supplement on HPV vaccines.

Author and Disclosure Information

Lea E. Widdice, MD
Assistant Professor of Pediatrics, Division of Adolescent Medicine, Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH

Jessica A. Kahn, MD, MPH
Associate Professor of Pediatrics, Director, Research Training, Division of Adolescent Medicine, Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH; Steering Committee, National Network for Immunization Information; HPV Expert Advisory Group,World Health Organization

Address: Lea E. Widdice, MD, Division of Adolescent Medicine, MLC 4000, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229; e-mail lea.widdice@cchmc.org

Dr. Kahn has disclosed that she has received a consulting fee from the SciMed and Merck corporations for editing a journal supplement on HPV vaccines.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 73(10)
Issue
Cleveland Clinic Journal of Medicine - 73(10)
Page Number
929-935
Page Number
929-935
Publications
Publications
Topics
Article Type
Display Headline
Using the new HPV vaccines in clinical practice
Display Headline
Using the new HPV vaccines in clinical practice
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

When can patients with acute deep vein thrombosis be allowed to get up and walk?

Article Type
Changed
Wed, 08/22/2018 - 10:52
Display Headline
When can patients with acute deep vein thrombosis be allowed to get up and walk?
Article PDF
Author and Disclosure Information

Leonard S. Feldman, MD
Hospitalist Program, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD

Daniel J. Brotman, MD
Director, Hospitalist Program, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD

Address: Daniel J. Brotman, MD, Director, Hospitalist Program, Department of Medicine, Johns Hopkins Hospital, Park 307, 600 North Wolfe Street, Baltimore, MD 21287; e-mail brotman@jhmi.edu

Dr. Feldman has indicated that he has received consulting fees from Quintiles Education, a supplier of evidence-based continuing medical education.

Issue
Cleveland Clinic Journal of Medicine - 73(10)
Publications
Topics
Page Number
893-894, 896
Sections
Author and Disclosure Information

Leonard S. Feldman, MD
Hospitalist Program, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD

Daniel J. Brotman, MD
Director, Hospitalist Program, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD

Address: Daniel J. Brotman, MD, Director, Hospitalist Program, Department of Medicine, Johns Hopkins Hospital, Park 307, 600 North Wolfe Street, Baltimore, MD 21287; e-mail brotman@jhmi.edu

Dr. Feldman has indicated that he has received consulting fees from Quintiles Education, a supplier of evidence-based continuing medical education.

Author and Disclosure Information

Leonard S. Feldman, MD
Hospitalist Program, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD

Daniel J. Brotman, MD
Director, Hospitalist Program, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD

Address: Daniel J. Brotman, MD, Director, Hospitalist Program, Department of Medicine, Johns Hopkins Hospital, Park 307, 600 North Wolfe Street, Baltimore, MD 21287; e-mail brotman@jhmi.edu

Dr. Feldman has indicated that he has received consulting fees from Quintiles Education, a supplier of evidence-based continuing medical education.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 73(10)
Issue
Cleveland Clinic Journal of Medicine - 73(10)
Page Number
893-894, 896
Page Number
893-894, 896
Publications
Publications
Topics
Article Type
Display Headline
When can patients with acute deep vein thrombosis be allowed to get up and walk?
Display Headline
When can patients with acute deep vein thrombosis be allowed to get up and walk?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Oil it where it squeaks: Evidence, experience, and osteoarthritis therapy

Article Type
Changed
Wed, 08/22/2018 - 10:32
Display Headline
Oil it where it squeaks: Evidence, experience, and osteoarthritis therapy
Article PDF
Author and Disclosure Information

Brian F. Mandell, MD, PhD
Editor in Chief

Issue
Cleveland Clinic Journal of Medicine - 73(10)
Publications
Topics
Page Number
880
Sections
Author and Disclosure Information

Brian F. Mandell, MD, PhD
Editor in Chief

Author and Disclosure Information

Brian F. Mandell, MD, PhD
Editor in Chief

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 73(10)
Issue
Cleveland Clinic Journal of Medicine - 73(10)
Page Number
880
Page Number
880
Publications
Publications
Topics
Article Type
Display Headline
Oil it where it squeaks: Evidence, experience, and osteoarthritis therapy
Display Headline
Oil it where it squeaks: Evidence, experience, and osteoarthritis therapy
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Intra-articular injections for osteoarthritis of the knee

Article Type
Changed
Wed, 08/22/2018 - 10:55
Display Headline
Intra-articular injections for osteoarthritis of the knee
Article PDF
Author and Disclosure Information

David H. Neustadt, MD
Clinical Professor of Medicine, University of Louisville School of Medicine, Louisville, KY

Address: David H. Neustadt, MD, Medical Towers South, 234 East Gray Street, Suite 328, Louisville, KY 40202

The author has indicated that he has served as a consultant for the Ortho Biotech Products corporation.

Issue
Cleveland Clinic Journal of Medicine - 73(10)
Publications
Topics
Page Number
897-898, 901-904, 906-911
Sections
Author and Disclosure Information

David H. Neustadt, MD
Clinical Professor of Medicine, University of Louisville School of Medicine, Louisville, KY

Address: David H. Neustadt, MD, Medical Towers South, 234 East Gray Street, Suite 328, Louisville, KY 40202

The author has indicated that he has served as a consultant for the Ortho Biotech Products corporation.

Author and Disclosure Information

David H. Neustadt, MD
Clinical Professor of Medicine, University of Louisville School of Medicine, Louisville, KY

Address: David H. Neustadt, MD, Medical Towers South, 234 East Gray Street, Suite 328, Louisville, KY 40202

The author has indicated that he has served as a consultant for the Ortho Biotech Products corporation.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 73(10)
Issue
Cleveland Clinic Journal of Medicine - 73(10)
Page Number
897-898, 901-904, 906-911
Page Number
897-898, 901-904, 906-911
Publications
Publications
Topics
Article Type
Display Headline
Intra-articular injections for osteoarthritis of the knee
Display Headline
Intra-articular injections for osteoarthritis of the knee
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Headaches in older patients: Special problems and concerns

Article Type
Changed
Wed, 08/22/2018 - 11:02
Display Headline
Headaches in older patients: Special problems and concerns
Article PDF
Author and Disclosure Information

Robert S. Kunkel, MD
Consultant, Cleveland Clinic Headache Center, Cleveland Clinic; past president, American Headache Society; past president, National Headache Foundation

Address: Robert S, Kunkel, MD, Headache Center, T33, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kunkelr@ccf.org

Issue
Cleveland Clinic Journal of Medicine - 73(10)
Publications
Topics
Page Number
922-928
Sections
Author and Disclosure Information

Robert S. Kunkel, MD
Consultant, Cleveland Clinic Headache Center, Cleveland Clinic; past president, American Headache Society; past president, National Headache Foundation

Address: Robert S, Kunkel, MD, Headache Center, T33, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kunkelr@ccf.org

Author and Disclosure Information

Robert S. Kunkel, MD
Consultant, Cleveland Clinic Headache Center, Cleveland Clinic; past president, American Headache Society; past president, National Headache Foundation

Address: Robert S, Kunkel, MD, Headache Center, T33, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kunkelr@ccf.org

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 73(10)
Issue
Cleveland Clinic Journal of Medicine - 73(10)
Page Number
922-928
Page Number
922-928
Publications
Publications
Topics
Article Type
Display Headline
Headaches in older patients: Special problems and concerns
Display Headline
Headaches in older patients: Special problems and concerns
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Effects of HIV Drugs on Serum Urate Levels

Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Effects of HIV Drugs on Serum Urate Levels

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 23(10)
Publications
Topics
Page Number
35
Legacy Keywords
HIV, serum uric acid, antiretroviral, urate, levelsHIV, serum uric acid, antiretroviral, urate, levels
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 23(10)
Issue
Federal Practitioner - 23(10)
Page Number
35
Page Number
35
Publications
Publications
Topics
Article Type
Display Headline
Effects of HIV Drugs on Serum Urate Levels
Display Headline
Effects of HIV Drugs on Serum Urate Levels
Legacy Keywords
HIV, serum uric acid, antiretroviral, urate, levelsHIV, serum uric acid, antiretroviral, urate, levels
Legacy Keywords
HIV, serum uric acid, antiretroviral, urate, levelsHIV, serum uric acid, antiretroviral, urate, levels
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media